Healthcare stocks
248 Healthcare companies worth $2B or more, largest first. The median scores 55/100 as of Oct 22, 2026. Each score blends technicals and fundamentals, with fundamentals judged against Healthcare ranges rather than the whole market. Another 446 smaller Healthcare companies are scored in the app.
| Company | Industry | Market cap | Score |
|---|---|---|---|
| LLY Eli Lilly and Company | Drug Manufacturers - General | $1.17T | 70 |
| JNJ Johnson & Johnson | Drug Manufacturers - General | $644.9B | 62 |
| ABBV AbbVie | Drug Manufacturers - General | $504.0B | 58 |
| UNH UnitedHealth Group | Healthcare Plans | $381.5B | 58 |
| MRK Merck & Co. | Drug Manufacturers - General | $363.3B | 59 |
| NVS Novartis AG | Drug Manufacturers - General | $297.0B | 63 |
| AZN AstraZeneca | Drug Manufacturers - General | $267.6B | 64 |
| TMO Thermo Fisher Scientific | Diagnostics & Research | $250.1B | 58 |
| AMGN Amgen | Drug Manufacturers - General | $241.8B | 66 |
| GILD Gilead Sciences | Drug Manufacturers - General | $194.9B | 62 |
| ABT Abbott Laboratories | Medical Devices | $177.4B | 49 |
| NVO Novo Nordisk A/S | Drug Manufacturers - General | $174.0B | 55 |
| PFE Pfizer | Drug Manufacturers - General | $173.4B | 54 |
| DHR Danaher | Diagnostics & Research | $161.5B | 57 |
| ISRG Intuitive Surgical | Medical Instruments & Supplies | $156.8B | 60 |
| VRTX Vertex Pharmaceuticals | Biotechnology | $135.6B | 65 |
| BMY Bristol-Myers Squibb Company | Drug Manufacturers - General | $128.7B | 66 |
| MDT Medtronic | Medical Devices | $123.6B | 59 |
| CVS CVS Health | Healthcare Plans | $120.8B | 58 |
| MCK McKesson | Medical Distribution | $118.0B | 64 |
| SYK Stryker | Medical Devices | $117.8B | 54 |
| GSK GSK | Drug Manufacturers - General | $102.6B | 61 |
| HCA HCA Healthcare | Medical Care Facilities | $101.2B | 64 |
| SNY Sanofi | Drug Manufacturers - General | $100.5B | 48 |
| ELV Elevance Health | Healthcare Plans | $96.6B | 58 |
| REGN Regeneron Pharmaceuticals | Biotechnology | $84.3B | 65 |
| CI The Cigna Group | Healthcare Plans | $83.5B | 64 |
| MRNA Moderna | Biotechnology | $80.9B | 47 |
| BSX Boston Scientific | Medical Devices | $66.7B | 56 |
| TAK Takeda Pharmaceutical Company | Drug Manufacturers - Specialty & Generic | $65.0B | 58 |
| COR Cencora | Medical Distribution | $64.6B | 60 |
| CAH Cardinal Health | Medical Distribution | $59.2B | 67 |
| NTRA Natera | Diagnostics & Research | $57.9B | 54 |
| ARGX argenx SE | Biotechnology | $55.1B | 64 |
| BDX Becton, Dickinson and Company | Medical Instruments & Supplies | $54.6B | 58 |
| VEEV Veeva Systems | Health Information Services | $52.2B | 65 |
| EW Edwards Lifesciences | Medical Devices | $51.9B | 58 |
| HUM Humana | Healthcare Plans | $50.6B | 57 |
| A Agilent Technologies | Diagnostics & Research | $49.0B | 59 |
| TEVA Teva Pharmaceutical Industries | Drug Manufacturers - Specialty & Generic | $46.9B | 58 |
| IQV IQVIA | Diagnostics & Research | $45.8B | 59 |
| HLN Haleon | Drug Manufacturers - Specialty & Generic | $45.6B | 61 |
| WAT Waters | Diagnostics & Research | $44.7B | 59 |
| IDXX IDEXX Laboratories | Diagnostics & Research | $44.6B | 61 |
| ONC BeOne Medicines AG | Biotechnology | $43.5B | 66 |
| ILMN Illumina | Diagnostics & Research | $40.7B | 59 |
| RVMD Revolution Medicines | Biotechnology | $40.2B | 43 |
| BIIB Biogen | Drug Manufacturers - General | $37.5B | 58 |
| RPRX Royalty Pharma | Biotechnology | $36.8B | 60 |
| RMD ResMed | Medical Instruments & Supplies | $35.6B | 66 |
| CNC Centene | Healthcare Plans | $35.2B | 59 |
| ALC Alcon | Medical Instruments & Supplies | $34.1B | 50 |
| ZTS Zoetis | Drug Manufacturers - Specialty & Generic | $33.9B | 54 |
| MTD Mettler-Toledo International | Diagnostics & Research | $33.8B | 59 |
| GEHC GE HealthCare Technologies | Medical Devices | $32.3B | 56 |
| ALNY Alnylam Pharmaceuticals | Biotechnology | $30.4B | 54 |
| DXCM DexCom | Medical Devices | $29.6B | 58 |
| WST West Pharmaceutical Services | Medical Instruments & Supplies | $27.7B | 58 |
| ROIV Roivant Sciences | Biotechnology | $27.1B | 48 |
| DGX Quest Diagnostics | Diagnostics & Research | $26.9B | 60 |
| LH Labcorp | Diagnostics & Research | $26.8B | 60 |
| PHG Koninklijke Philips | Medical Devices | $26.3B | 53 |
| UTHR United Therapeutics | Drug Manufacturers - Specialty & Generic | $25.1B | 68 |
| GMAB Genmab A/S | Biotechnology | $24.6B | 67 |
| INCY Incyte | Biotechnology | $23.7B | 67 |
| STE STERIS | Medical Devices | $22.6B | 61 |
| BNTX BioNTech SE | Biotechnology | $22.5B | 34 |
| GH Guardant Health | Diagnostics & Research | $21.9B | 52 |
| THC Tenet Healthcare | Medical Care Facilities | $21.8B | 66 |
| VTRS Viatris | Drug Manufacturers - Specialty & Generic | $21.2B | 51 |
| INSM Insmed | Biotechnology | $20.8B | 41 |
| ZBH Zimmer Biomet | Medical Devices | $18.8B | 55 |
| MEDP Medpace | Diagnostics & Research | $18.3B | 67 |
| RVTY Revvity | Diagnostics & Research | $17.6B | 53 |
| CRL Charles River Laboratories International | Diagnostics & Research | $16.4B | 53 |
| EXEL Exelixis | Biotechnology | $16.2B | 73 |
| ASND Ascendis Pharma A/S | Biotechnology | $16.0B | 63 |
| SOLV Solventum | Medical Instruments & Supplies | $14.9B | 60 |
| NBIX Neurocrine Biosciences | Drug Manufacturers - Specialty & Generic | $14.6B | 66 |
| ICLR ICON Public Limited Company | Diagnostics & Research | $14.3B | 52 |
| HALO Halozyme Therapeutics | Biotechnology | $14.1B | 69 |
| JAZZ Jazz Pharmaceuticals | Biotechnology | $13.9B | 57 |
| BBIO BridgeBio Pharma | Biotechnology | $13.3B | 48 |
| BAX Baxter International | Medical Instruments & Supplies | $13.3B | 43 |
| SNN Smith & Nephew | Medical Devices | $12.9B | 58 |
| PEN Penumbra | Medical Devices | $12.8B | 60 |
| EHC Encompass Health | Medical Care Facilities | $12.4B | 65 |
| SMMT Summit Therapeutics | Biotechnology | $12.4B | 40 |
| BTSG BrightSpring Health Services | Health Information Services | $12.0B | 63 |
| DVA DaVita | Medical Care Facilities | $11.9B | 61 |
| FMS Fresenius Medical Care AG | Medical Care Facilities | $11.8B | 48 |
| COO The Cooper Companies | Medical Instruments & Supplies | $11.7B | 50 |
| CORT Corcept Therapeutics | Biotechnology | $11.6B | 56 |
| AVTR Avantor | Medical Instruments & Supplies | $11.6B | 49 |
| TEM Tempus AI | Health Information Services | $11.5B | 47 |
| TECH Bio-Techne | Biotechnology | $11.4B | 58 |
| RGEN Repligen | Medical Instruments & Supplies | $11.3B | 54 |
| ELAN Elanco Animal Health | Drug Manufacturers - Specialty & Generic | $11.3B | 47 |
| MOH Molina Healthcare | Healthcare Plans | $11.3B | 50 |
| UHS Universal Health Services | Medical Care Facilities | $11.1B | 64 |
| ALGN Align Technology | Medical Instruments & Supplies | $11.0B | 49 |
| RDY Dr. Reddy's Laboratories | Drug Manufacturers - Specialty & Generic | $11.0B | 54 |
| GMED Globus Medical | Medical Devices | $11.0B | 68 |
| BMRN BioMarin Pharmaceutical | Biotechnology | $11.0B | 47 |
| MDGL Madrigal Pharmaceuticals | Biotechnology | $10.5B | 43 |
| GKOS Glaukos | Medical Devices | $10.4B | 54 |
| ENSG The Ensign Group | Medical Care Facilities | $10.4B | 61 |
| QGEN Qiagen | Diagnostics & Research | $10.4B | 61 |
| OSCR Oscar Health | Healthcare Plans | $10.3B | 62 |
| PODD Insulet | Medical Devices | $10.3B | 54 |
| PCVX Vaxcyte | Biotechnology | $9.9B | 47 |
| BIO Bio-Rad Laboratories | Medical Devices | $9.7B | 54 |
| HSIC Henry Schein | Medical Distribution | $9.6B | 56 |
| KRYS Krystal Biotech | Biotechnology | $9.5B | 65 |
| KYMR Kymera Therapeutics | Biotechnology | $9.1B | 50 |
| TXG 10x Genomics | Medical Devices | $9.1B | 47 |
| PTGX Protagonist Therapeutics | Biotechnology | $9.0B | 57 |
| TWST Twist Bioscience | Biotechnology | $9.0B | 49 |
| CAI Caris Life Sciences | Biotechnology | $9.0B | 57 |
| HNGE Hinge Health | Health Information Services | $8.9B | 63 |
| IBRX ImmunityBio | Biotechnology | $8.8B | 51 |
| BRKR Bruker | Medical Devices | $8.7B | 48 |
| CYTK Cytokinetics | Biotechnology | $8.7B | 44 |
| SYRE Spyre Therapeutics | Biotechnology | $8.6B | 52 |
| HQY HealthEquity | Health Information Services | $8.4B | 67 |
| ARWR Arrowhead Pharmaceuticals | Biotechnology | $8.2B | 47 |
| AXSM Axsome Therapeutics | Biotechnology | $8.2B | 43 |
| ATR AptarGroup | Medical Instruments & Supplies | $8.1B | 56 |
| TGTX TG Therapeutics | Biotechnology | $8.1B | 66 |
| ABVX ABIVAX Société Anonyme | Biotechnology | $7.9B | 37 |
| PACS PACS Group | Medical Care Facilities | $7.5B | 70 |
| ALKS Alkermes | Drug Manufacturers - Specialty & Generic | $7.4B | 58 |
| IONS Ionis Pharmaceuticals | Biotechnology | $7.3B | 34 |
| PRAX Praxis Precision Medicines | Biotechnology | $7.2B | 45 |
| AMRX Amneal Pharmaceuticals | Drug Manufacturers - Specialty & Generic | $7.1B | 65 |
| CHE Chemed | Medical Care Facilities | $6.8B | 60 |
| HIMS Hims & Hers Health | Drug Manufacturers - Specialty & Generic | $6.8B | 51 |
| LNTH Lantheus | Drug Manufacturers - Specialty & Generic | $6.5B | 65 |
| IOVA Iovance Biotherapeutics | Biotechnology | $6.4B | 52 |
| KNSA Kiniksa Pharmaceuticals International | Drug Manufacturers - Specialty & Generic | $6.3B | 65 |
| RYTM Rhythm Pharmaceuticals | Biotechnology | $6.3B | 46 |
| BLCO Bausch + Lomb | Medical Instruments & Supplies | $6.2B | 53 |
| LGND Ligand Pharmaceuticals | Biotechnology | $6.1B | 64 |
| BLTE Belite Bio | Biotechnology | $6.1B | 42 |
| IMVT Immunovant | Biotechnology | $6.0B | 40 |
| DOCS Doximity | Health Information Services | $6.0B | 56 |
| TFX Teleflex | Medical Instruments & Supplies | $5.8B | 43 |
| GRAL GRAIL | Diagnostics & Research | $5.7B | 53 |
| MMSI Merit Medical Systems | Medical Instruments & Supplies | $5.6B | 64 |
| WAY Waystar Holding | Health Information Services | $5.6B | 63 |
| CGON CG Oncology | Biotechnology | $5.5B | 47 |
| RDNT RadNet | Diagnostics & Research | $5.5B | 50 |
| COGT Cogent Biosciences | Biotechnology | $5.4B | 44 |
| MIRM Mirum Pharmaceuticals | Biotechnology | $5.4B | 48 |
| KOD Kodiak Sciences | Biotechnology | $5.4B | 48 |
| ORKA Oruka Therapeutics | Biotechnology | $5.4B | 42 |
| STVN Stevanato Group S.p.A. | Medical Instruments & Supplies | $5.3B | 47 |
| HAE Haemonetics | Medical Devices | $5.3B | 58 |
| PTCT PTC Therapeutics | Biotechnology | $5.3B | 63 |
| SHC Sotera Health Company | Diagnostics & Research | $5.2B | 61 |
| SRRK Scholar Rock Holding | Biotechnology | $5.1B | 44 |
| CON Concentra Group Holdings Parent | Medical Care Facilities | $5.1B | 68 |
| GRFS Grifols | Drug Manufacturers - General | $5.1B | 47 |
| TVTX Travere Therapeutics | Biotechnology | $4.9B | 50 |
| ERAS Erasca | Biotechnology | $4.9B | 44 |
| RGC Regencell Bioscience Holdings | Drug Manufacturers - Specialty & Generic | $4.9B | 36 |
| CRSP CRISPR Therapeutics AG | Biotechnology | $4.8B | 37 |
| HTFL Heartflow | Health Information Services | $4.8B | 55 |
| LFST LifeStance Health Group | Medical Care Facilities | $4.8B | 64 |
| TNGX Tango Therapeutics | Biotechnology | $4.7B | 54 |
| OPCH Option Care Health | Medical Care Facilities | $4.7B | 60 |
| LIVN LivaNova | Medical Devices | $4.5B | 60 |
| DNTH Dianthus Therapeutics | Biotechnology | $4.4B | 45 |
| EWTX Edgewise Therapeutics | Biotechnology | $4.3B | 46 |
| ITGR Integer Holdings | Medical Devices | $4.3B | 56 |
| ICUI ICU Medical | Medical Instruments & Supplies | $4.2B | 56 |
| INDV Indivior Pharmaceuticals | Drug Manufacturers - Specialty & Generic | $4.2B | 66 |
| ARQT Arcutis Biotherapeutics | Biotechnology | $4.0B | 61 |
| RLAY Relay Therapeutics | Biotechnology | $4.0B | 50 |
| IRTC iRhythm | Medical Devices | $3.9B | 48 |
| ADPT Adaptive Biotechnologies | Diagnostics & Research | $3.9B | 49 |
| NVST Envista Holdings | Medical Instruments & Supplies | $3.9B | 50 |
| NHC National HealthCare | Medical Care Facilities | $3.8B | 65 |
| PLSE Pulse Biosciences | Medical Instruments & Supplies | $3.8B | 49 |
| VCYT Veracyte | Diagnostics & Research | $3.7B | 65 |
| ABCL AbCellera Biologics | Biotechnology | $3.7B | 50 |
| LEGN Legend Biotech | Biotechnology | $3.7B | 41 |
| OGN Organon & | Drug Manufacturers - General | $3.6B | 52 |
| AMLX Amylyx Pharmaceuticals | Drug Manufacturers - Specialty & Generic | $3.6B | 54 |
| CDNA CareDx | Diagnostics & Research | $3.6B | 55 |
| LQDA Liquidia | Drug Manufacturers - Specialty & Generic | $3.6B | 56 |
| XENE Xenon Pharmaceuticals | Biotechnology | $3.5B | 36 |
| ACAD Acadia Pharmaceuticals | Biotechnology | $3.5B | 52 |
| IDYA IDEAYA Biosciences | Biotechnology | $3.5B | 50 |
| TARS Tarsus Pharmaceuticals | Biotechnology | $3.4B | 52 |
| VKTX Viking Therapeutics | Biotechnology | $3.3B | 32 |
| TLX Telix Pharmaceuticals | Biotechnology | $3.2B | 43 |
| CELC Celcuity | Biotechnology | $3.2B | 36 |
| WRBY Warby Parker | Medical Instruments & Supplies | $3.2B | 57 |
| ELVN Enliven Therapeutics | Biotechnology | $3.1B | 45 |
| ATRC AtriCure | Medical Instruments & Supplies | $3.0B | 56 |
| DNLI Denali Therapeutics | Biotechnology | $3.0B | 37 |
| ACHC Acadia Healthcare Company | Medical Care Facilities | $3.0B | 46 |
| DYN Dyne Therapeutics | Biotechnology | $2.9B | 34 |
| PRVA Privia Health Group | Health Information Services | $2.9B | 56 |
| AVAH Aveanna Healthcare | Medical Care Facilities | $2.9B | 70 |
| IRON Disc Medicine | Biotechnology | $2.9B | 45 |
| NRIX Nurix Therapeutics | Biotechnology | $2.8B | 63 |
| MRVI Maravai LifeSciences | Biotechnology | $2.6B | 44 |
| NEOG Neogen | Medical Devices | $2.6B | 45 |
| VRDN Viridian Therapeutics | Biotechnology | $2.6B | 48 |
| BEAM Beam Therapeutics | Biotechnology | $2.5B | 39 |
| NAMS NewAmsterdam Pharma Company | Biotechnology | $2.5B | 39 |
| CLOV Clover Health Investments | Healthcare Plans | $2.5B | 55 |
| GRDN Guardian Pharmacy Services | Medical Care Facilities | $2.5B | 62 |
| TMDX TransMedics Group | Medical Devices | $2.5B | 54 |
| HCM HUTCHMED (China) | Drug Manufacturers - Specialty & Generic | $2.5B | 55 |
| ZLAB Zai Lab | Biotechnology | $2.5B | 37 |
| ADMA ADMA Biologics | Biotechnology | $2.5B | 62 |
| SUPN Supernus Pharmaceuticals | Drug Manufacturers - Specialty & Generic | $2.4B | 44 |
| RCUS Arcus Biosciences | Biotechnology | $2.4B | 36 |
| BKD Brookdale Senior Living | Medical Care Facilities | $2.4B | 40 |
| MBX MBX Biosciences | Biotechnology | $2.4B | 46 |
| BHC Bausch Health Companies | Drug Manufacturers - Specialty & Generic | $2.4B | 57 |
| MD Pediatrix Medical Group | Medical Care Facilities | $2.4B | 63 |
| PBH Prestige Consumer Healthcare | Drug Manufacturers - Specialty & Generic | $2.3B | 49 |
| AUPH Aurinia Pharmaceuticals | Biotechnology | $2.3B | 76 |
| UFPT UFP Technologies | Medical Devices | $2.3B | 65 |
| SLS SELLAS Life Sciences Group | Biotechnology | $2.3B | 48 |
| ADUS Addus HomeCare | Medical Care Facilities | $2.3B | 66 |
| PGEN Precigen | Biotechnology | $2.3B | 46 |
| CLDX Celldex Therapeutics | Biotechnology | $2.3B | 30 |
| FTRE Fortrea | Biotechnology | $2.3B | 52 |
| PRGO Perrigo Company | Drug Manufacturers - Specialty & Generic | $2.3B | 43 |
| PGNY Progyny | Healthcare Plans | $2.2B | 66 |
| AGIO Agios Pharmaceuticals | Biotechnology | $2.2B | 49 |
| BHVN Biohaven | Biotechnology | $2.2B | 43 |
| VCEL Vericel | Biotechnology | $2.2B | 58 |
| IMNM Immunome | Biotechnology | $2.2B | 41 |
| PHVS Pharvaris | Biotechnology | $2.2B | 42 |
| AXGN Axogen | Medical Devices | $2.2B | 47 |
| NEO NeoGenomics | Diagnostics & Research | $2.1B | 49 |
| INSP Inspire Medical Systems | Medical Devices | $2.1B | 59 |
| HRMY Harmony Biosciences | Biotechnology | $2.1B | 68 |
| VERA Vera Therapeutics | Biotechnology | $2.1B | 36 |
| SGRY Surgery Partners | Medical Care Facilities | $2.1B | 46 |
| ZYME Zymeworks | Biotechnology | $2.0B | 52 |
| WGS GeneDx Holdings | Diagnostics & Research | $2.0B | 40 |